Developing Novel Therapeutics Based on Naturally Occurring Resistance Mechanisms

CaVos Biotech has developed a multi-layer computational algorithm which uses comparative analysis of hundreds of animal genomes to uncover the genetic basis of extraordinary cancer resistance and longevity found in some species.

The company is harnessing the genomic and data science revolution to discover high resolution novel gene targets and develop precision therapeutics to mimic existing anti-cancer mechanisms.